S 3133
116th Congress
Senate
Health
Civil actions and liability
Drug safety, medical device, and laboratory regulation
Health care coverage and access
Health information and medical records
Licensing and registrations
Marketing and advertising
Medical research
Conditional Approval Act
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 19, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Dec 19, 2019
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Conditional Approval Act
This bill authorizes the Food and Drug Administration to conditionally approve certain new drugs intended for diseases that are seriously debilitating, life threatening, or chronic, and for which meaningful treatments do not exist. The bill also limits liability related to these conditionally approved drugs.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Related & companion bills
1
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cosponsors
1
Cite this page
U.S. Congress. (2026). S. 3133: Conditional Approval Act. 116th Congress. Open America. https://openamerica.io/bill/116-S-3133/
"S. 3133: Conditional Approval Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-3133/.
S. 3133, 116th Cong. (2026), https://openamerica.io/bill/116-S-3133/.
[S. 3133: Conditional Approval Act](https://openamerica.io/bill/116-S-3133/)